Supreme Court Rules in Favor of Teva in Copaxone Patent by REUTERS

By REUTERS

The court said the company could still benefit from patent protection for the multiple sclerosis drug, dealing a blow to makers of generic drugs.

Published: January 21, 2015 at 12:00AM

from NYT Business Day http://ift.tt/1EncKDO

from WordPress http://ift.tt/1BABCd0

via Hadi Aboukhater